Displaying items by tag: Alzheimer's

Australian researchers for global tech company IBM have applied machine learning to identify proteins in blood that can predict Alzheimer’s disease risk.

Published in Science

Australian company Actinogen Medical is developing a new drug — Xanamem that blocks the excess production of stress hormone cortisol in Alzheimer’s sufferers, offering a potential treatment for the disease.

Published in Health

"There's an app for that" is a cliche, and the phrase "ageing population" often turns up in political discourse. But even if there's a person with dementia in your family, would you have thought of an app that can make their home more accessible for them?

Published in Mobility
Page 1 of 3

WEBINARS ONLINE & DEMAND

GUEST ARTICLES

VENDOR NEWS

Guest Opinion

Guest Interviews

Guest Reviews

ResearchWire

Guest Research & Case Studies

Channel News

Comments